EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,000 | -33.3% | 1,690 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 1,690 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | 0.0% | 1,690 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +14.3% | 1,690 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | -12.5% | 1,690 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -11.1% | 1,690 | 0.0% | 0.00% | – |
| Q1 2020 | $9,000 | -47.1% | 1,690 | 0.0% | 0.00% | – |
| Q4 2019 | $17,000 | +466.7% | 1,690 | +105.1% | 0.00% | – |
| Q3 2019 | $3,000 | – | 824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,815,500 | $8,950,000 | 0.30% |
| Sterling Financial Planning, Inc. | 1,171 | $6,000 | 0.01% |
| UBS Group AG | 3,991 | $20,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 468 | $2,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,656 | $62,000 | 0.00% |
| North Star Investment Management Corp. | 20 | $0 | 0.00% |
| MORGAN STANLEY | 466 | $2,000 | 0.00% |